-
Database Identifies Unhealthy Ultra-Processed Foods
An innovative database developed by researchers at Mass General Brigham in Boston can now help you find the most nutritious prepared foods, while steering clear of unhealthful ultra-processed foods. Ultra-processed foods, typically full of hidden sugars, unhealthy fats, and...
-
GLP-1 Drugs Lower Risk for 42 Health Conditions
Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions such as substance abuse, psychosis, infections and even dementia. But these drugs also come with risks that shouldn't be overlooked, researchers warn in a...
-
FDA Proposes New Front-of-Package Food Labels
Grabbing a quick snack might soon come with a little extra clarity. The U.S. Food and Drug Administration (FDA) has proposed a new rule requiring bold, easy-to-read nutrition labels on the front of food and beverage packages. These labels, which would highlight content of...
-
Diabetes Drug Protects Against Skin Cancer
A popular diabetes drug can provide protection against skin cancers, a new study says. Metformin significantly reduces people's risk of developing basal cell cancers or squamous cell cancers, the two most common skin cancers, researchers found in a recent study published in...
-
Fecal Transplants Benefit Diabetes, Gut Issues
A fecal transplant could help people whose Type 1 diabetes has fouled up their digestive system. Swallowing a handful of capsules filled with donor feces helped ease gut pain, nausea, bloating and diarrhea stemming from diabetes, researchers reported in a study published...
-
How Elderberry Juice Can Help You Lose Weight
Ozempic? Wegovy? Zepbound? How about elderberry juice? Elderberry juice might help people lose weight and improve their blood sugar control, a new small-scale study says. People who drank 12 ounces of elderberry juice daily for a week wound up with better blood sugar levels,...
-
Obesity Drug Gets Medicare Coverage for Sleep Apnea
Eli Lilly's popular obesity drug Zepbound can now be covered by government-backed Medicare drug plans, the Centers for Medicare & Medicaid Services said on Wednesday. Zepbound in December became the first drug approved in the U.S. for sleep apnea, but commercial insurers and...
-
Study: GLP-1s That Achieve the Most Weight Loss
Three GLP-1 drugs are best at helping obese and overweight people drop weight, including one that hasn't yet been approved for that purpose. A new evidence review published in the Annals of Internal Medicine shows that the widely-known drugs tirzepatide (Zepbound) and...
-
How GLP-1 Weight Loss Drugs Boost Heart Health
Weight loss tops many folks' list of New Years resolutions, and lots of people are turning to cutting-edge weight-loss drugs like Ozempic to help them drop excess pounds. These drugs, called glucagon-like peptide-1 receptor agonists (GLP-1 RAs), work in several different...
-
The Top Health Stories of 2024
It was a year in health news that will be hard to forget. As blockbuster weight-loss drugs known as GLP-1s made a sizable dent in the obesity epidemic, study after study revealed other ways in which these powerful medications can improve health. At the same time, multiple...
-
FDA: Lilly Weight-Loss Drug Shortage Resolved
The U.S. Food and Drug Administration said on Thursday that Eli Lilly's weight-loss drug shortage has been resolved, following a re-evaluation of the drug's supply by the agency. Still, the FDA said it would not take any action against compounding pharmacies making cheaper...
-
Novo Responds to Ozempic's Link to Rare Eye Disease
Danish health authorities said on Monday they would ask the European Union's drug regulator to review the findings of two Danish studies linking Novo Nordisk's popular diabetes drug Ozempic to a rare sight-threatening eye condition. The two studies conducted by University of...
-
Common Blood Test Could Spot Multiple Diseases
A blood draw is a typical part of a person's regular check-up. But that blood sample might hold a lot more useful information about a person's health than doctors are currently getting. A new study shows that a routine part of a blood test called the complete blood count...
-
Half of Calories Eaten at Home are Ultra-Processed
Unhealthy ultra-processed foods have wormed their way into American kitchens, likely harming people's health for decades, a new study warns. More than half of the calories adults eat at home now come from ultra-processed foods, which contain high levels of sugar, salt, fat...
-
Dr. Crandall: Drink Coffee for a Healthier Heart
It seems like the news on whether drinking coffee is detrimental, or beneficial, to our health flip flops all the time. But now a new study brings good news to those of us who like to enjoy a hot cup of coffee, or three. Drinking coffee can help protect against heart...
-
6 Promising Health Benefits of Weight Loss Drugs
Weight loss drugs, including Ozempic, can help people lose about 15% of their body weight. Semaglutide, the generic name for Wegovy and Ozempic, was designed to treat diabetes, but was found to be help obese men and women shed unwanted pounds. And now, doctors are finding...
-
Study: Zepbound Improves Heart Failure Symptoms
A drug used to help patients lose weight and manage diabetes may also help those with heart failure, an international clinical trial shows.The test of tirzepatide, brand named Zepbound, included 731 patients with diastolic heart failure and obesity who were followed for two...
-
Diabetes Diagnosis Before 50 Raises Dementia Risk
A Type 2 diabetes diagnosis before age 50 comes with a health risk that patients might not expect. Especially if they are obese, these folks are more likely to develop dementia later, new research warns. "Our study suggests that there may be a cognitive consequences to...
-
Half of Americans May Be Candidates for Ozempic
More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug semaglutide, a new analysis finds. Sold as Ozempic for treating diabetes and Wegovy to spur weight loss, the medication could be indicated for those two...
-
Diabetes Cases Have Doubled: Protect Yourself
Diabetes rates have doubled worldwide in the last 30 years, according to new statistics published this week in The Lancet journal. The study authors note that this is the first global analysis of the number of diabetes cases and treatment rates that includes all...
-
How GLP-1 Weight Loss Meds Curb Alcohol Abuse
There have been a slew of studies recently supporting the notion that the same mechanisms that help folks lose weight with Ozempic and its kin also work to curb problem drinking. Now, a new study out of Britain adds to that growing pile of evidence. "Our findings show that...
-
Lilly Weight-Loss Drug Keeps Patients Diabetes-Free
Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of weekly injections. The results suggest that tirzepatide - the active ingredient in Lilly's diabetes drug Mounjaro and weight-loss treatment Zepbound -...
-
Diabetes Rates Have Doubled Worldwide in 30 Years
Fourteen percent of the world's people - more than 800 million - now have diabetes, a doubling of the global rate for the blood sugar disease since 1990, new statistics show. Type 2 diabetes, which makes up 95% of cases, is surging in poorer countries. However, across these...
-
US Diabetes Rates Rise to Nearly 1 in 6 Adults
Nearly 16% of American adults - that's close to 1 in 6 - now has diabetes, according to the latest data from the U.S. Centers for Disease Control and Prevention. Increasing age and widening waistlines greatly increase the odds for the disease, which happens when the body...
-
Medicaid Covers GLP-1 Obesity Meds in Just 13 States
Poorer folks' access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found. Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers discovered. Under...